Mustang Bio (MBIO) Shares Outstanding (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Shares Outstanding (Entity) of $6.7 million for Q1 2026, up 166.3% year-over-year from $2.5 million in Q1 2025, and up 37.16% quarter-over-quarter from $4.9 million in Q4 2025.
Mustang Bio (MBIO) Shares Outstanding (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Shares Outstanding (Entity) for 11 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 166.3% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $6.7 million (up 166.3% YoY), while the FY2025 annual figure was $4.9 million, up 705.02% from the prior year.
- Shares Outstanding (Entity) advanced to $6.7 million in Q1 2026 per MBIO's latest filing, from $4.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $6.7 million in Q1 2026 and bottomed at $133724.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $1.6 million across 5 years, with a median of $190911.0 in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) grew 5.01% — and 2025, when it surged 1224.2%.
- Mustang Bio's Shares Outstanding (Entity) stood at $142002.0 in 2022, then rose by 17.95% to $167497.0 in 2023, then surged by 264.0% to $609696.0 in 2024, then jumped by 705.02% to $4.9 million in 2025, then soared by 37.16% to $6.7 million in 2026.
- Business Quant data shows MBIO's Shares Outstanding (Entity) at $6.7 million in Q1 2026, $4.9 million in Q4 2025, and $6.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | 6.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.73 Mn |
| Mar 31, 2026 | 6.73 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 4.02 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Dec 31, 2024 | 609,696.00 |
| Sep 30, 2024 | 736,809.00 |
| Jun 30, 2024 | 462,464.00 |
| Mar 31, 2024 | 225,075.00 |
| Dec 31, 2023 | 172,082.00 |
| Sep 30, 2023 | 163,432.00 |
| Jun 30, 2023 | 162,549.00 |
| Mar 31, 2023 | 161,873.00 |
| Dec 31, 2022 | 137,917.00 |
| Sep 30, 2022 | 141,231.00 |
| Jun 30, 2022 | 137,270.00 |
| Mar 31, 2022 | 130,560.00 |
| Dec 31, 2021 | 117,186.00 |
| Sep 30, 2021 | 121,522.00 |